Rabbit Anti-Horse IgG H&L (HRP) (ab6921)
Key features and details
- Rabbit Anti-Horse IgG H&L (HRP)
- Conjugation: HRP
- Host species: Rabbit
- Isotype: IgG
- Suitable for: ICC/IF, IHC-Fr, Immunomicroscopy, WB, IHC-P, ELISA, Dot blot
Related conjugates and formulations
製品の概要
-
製品名
Rabbit Anti-Horse IgG H&L (HRP)
IgG 二次抗体 製品一覧 -
由来種
Rabbit -
ターゲット生物種
Horse -
アプリケーション
適用あり: ICC/IF, IHC-Fr, Immunomicroscopy, WB, IHC-P, ELISA, Dot blotmore details -
免疫原
Full length native horse IgG (purified).
-
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
Preservative: 0.01% Gentamicin sulphate
Constituents: 0.878% Sodium chloride, 1% BSA, 0.424% Potassium phosphate -
Concentration information loading... -
精製度
Affinity purified -
特記事項（精製）
This product was prepared from monospecific antiserum by immunoaffinity chromatography using horse IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities -
特記事項（標識）
Horseradish Peroxidase (HRP) -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab6921の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| ICC/IF |
1/500 - 1/2500.
|
|
| IHC-Fr |
Use at an assay dependent dilution.
|
|
| Immunomicroscopy |
Use at an assay dependent dilution.
|
|
| WB |
1/5000 - 1/20000.
|
|
| IHC-P |
Use at an assay dependent dilution.
|
|
| ELISA |
1/50000 - 1/200000.
|
|
| Dot blot |
Use at an assay dependent dilution.
|
| 特記事項 |
|---|
|
ICC/IF
1/500 - 1/2500. |
|
IHC-Fr
Use at an assay dependent dilution. |
|
Immunomicroscopy
Use at an assay dependent dilution. |
|
WB
1/5000 - 1/20000. |
|
IHC-P
Use at an assay dependent dilution. |
|
ELISA
1/50000 - 1/200000. |
|
Dot blot
Use at an assay dependent dilution. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (8)
ab6921 は 8 報の論文で使用されています。
- Spoerry C et al. Novel IgG-Degrading Enzymes of the IgdE Protease Family Link Substrate Specificity to Host Tropism of Streptococcus Species. PLoS One 11:e0164809 (2016). PubMed: 27749921
- Scheel TK et al. Characterization of nonprimate hepacivirus and construction of a functional molecular clone. Proc Natl Acad Sci U S A 112:2192-7 (2015). PubMed: 25646476
- Endmann A et al. Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine. PLoS One 9:e101715 (2014). WB . PubMed: 24992038
- Kong L et al. HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro. PLoS One 9:e83728 (2014). PubMed: 24586227
- Qin Y et al. Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates. J Clin Microbiol 49:1226-33 (2011). PubMed: 21289153
- Qin Y et al. Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity. J Virol 85:10167-77 (2011). PubMed: 21775451
- Guarnieri M et al. Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression. J Virol 80:587-95 (2006). PubMed: 16378961
- Lee SC et al. Structural basis of citrate-dependent and heparan sulfate-mediated cell surface retention of cobra cardiotoxin A3. J Biol Chem 280:9567-77 (2005). PubMed: 15590643